Skip to main content
← Back to work

Works cited by this work

199 works

Work: Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?

  1. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy

    X. Xia, Zongxin Yang, Qisi Lu +6

    Review article20242 citations
    ABI
  2. In vivo CAR T cell generation to treat cancer and autoimmune disease

    Theresa Hunter, Yanjie Bao, Yan Zhang +37

    Article20252 citations
    ABI
  3. Untitled

    Other1 citations
    ABI
  4. Untitled

    Other1 citations
    ABI
  5. Untitled

    Other1 citations
    ABI
  6. Untitled

    Other1 citations
    ABI
  7. Untitled

    Other1 citations
    ABI
  8. Untitled

    Other1 citations
    ABI
  9. Untitled

    Other1 citations
    ABI
  10. Untitled

    Other1 citations
    ABI
  11. Untitled

    Other1 citations
    ABI
  12. Untitled

    Other1 citations
    ABI
  13. Untitled

    Other1 citations
    ABI
  14. Untitled

    Other1 citations
    ABI
  15. Untitled

    Other1 citations
    ABI
  16. Untitled

    Other1 citations
    ABI
  17. Untitled

    Other1 citations
    ABI